Clinical Trial Update: 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating whether six cycles of neoadjuvant chemotherapy provide different outcomes than three cycles for potentially resec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Thymoma and Thymic Carcinoma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING